Loading...
ORGN logo
ORGN
Origin Materials

CapFormer Will Transform $65B PET Caps Market Amid Risks

Published
20 Apr 25
Updated
01 May 25
AnalystConsensusTarget's Fair Value
US$0.46
16.0% overvalued intrinsic discount
11 Jun
US$0.53
Loading
1Y
-63.5%
7D
2.2%

Author's Valuation

US$0.4616.0% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates2

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on24 Apr 25
Fair value Decreased 8.00%

AnalystConsensusTarget has decreased future PE multiple from 6.7x to 6.0x and decreased shares outstanding growth rate from 0.1% to -0.0%.

Read more